Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2019
Event: Entry into a Material Definitive Agreement (First Amendment to Credit Agreement).
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, or liquidity ratios. The document focuses exclusively on the amendment of a credit facility.
Material Changes
On November 12, 2019, the Company entered into a First Amendment to its Credit Agreement with Silicon Valley Bank (SVB). The amendment modifies Section 6.20 of the original agreement dated March 14, 2019, establishing two new covenants regarding lease agreements:
- Collateral Assignment: The Company must provide fully executed Collateral Assignments of Leases, Right to Assign Leases, and Landlord's Consents for four specific properties (65, 85, 150, and 275 Dan Road) by December 31, 2019.
- Lease Extension: The Company must enter into written amendments or extensions for these leases to extend their termination dates beyond the Revolving Termination Date and Term Loan Maturity Date by December 31, 2021.
Guidance, Outlook, and Risks
The filing contains no management guidance, outlook, or discussion of general business risks. The primary contingency identified is the Company's obligation to satisfy the new lease-related covenants by the specified deadlines to maintain compliance with the Credit Agreement.
Investor Verification Checklist
- Verify the execution status of the Collateral Assignments and Landlord Consents for the four Dan Road properties by the December 31, 2019 deadline.
- Confirm the terms of the original Credit Agreement to understand the specific "Revolving Termination Date" and "Term Loan Maturity Date" referenced in the extension covenant.
- Review the full text of the First Amendment (Exhibit 10.1) for any additional conditions or definitions not summarized in the 8-K.